Sanofi-aventis' India SITE study shows 62% of diabetic population in New Delhi has 'uncontrolled' diabetes: "Sanofi-aventis' India SITE study shows 62% of diabetic population in New Delhi has 'uncontrolled' diabetes
Study also reveals prevalence of 'uncontrolled' lipid levels (dyslipidemia)is much higher in New Delhi at 50% compared to 18% in Maharshtra Gurgaon, Haryana, May 12, 2010 /India PRwire/ -- Aventis Pharma Limited (sanofi-aventis Group) today announced the New Delhi results of the SITE (Screening India's Twin Epidemic) study. The New Delhi results follow the Maharashtra results announcement in November 2009. The results of other States covered in the SITE study will be shared over the next few months.
SITE is the first cross-sectional study to assess the prevalence of diagnosed and undiagnosed cases of diabetes and hypertension amongst nearly 20,000 patients visiting General Practitioners and Consultant Physicians across major cities all over India. The SITE study has been commissioned by sanofi-aventis in order to quantify and increase awareness of diabetes and hypertension becoming twin epidemics in India" Click on link above for full article.